eggXYt

Company Overview

Snapshot

Founded in October 2016 by Yehuda Elram, Daniel Offen, and Gal Lin, eggXYt operates with 1–10 employees. The company has raised $604K across four funding rounds.

Business overview

eggXYt is an Agriculture & Food Technologies company developing a CRISPR-based proprietary technology for the pre-incubation sex identification of chick embryos. This technology detects the sex of chick embryos immediately after eggs are laid, before the 21-day incubation period. By preventing the unnecessary incubation of male chicks, eggXYt addresses ethical, environmental, and economic challenges in egg and poultry production, aiming to reduce the culling of male chicks and keep eggs within the food industry. The company operates within the sustainable farming, agtech, and genetics sectors, serving the global agriculture and food markets, particularly the livestock and poultry industries.

Strategic signal

In December 2020, eggXYt licensed the GEiGS™ Technology Platform from Tropic Biosciences to develop resistance against the Avian Influenza Virus in chickens. This strategic collaboration signals eggXYt's expansion beyond sex identification into broader poultry health and disease prevention, leveraging gene-editing technology to address critical industry challenges. For investors, this indicates a potential for diversified revenue streams and a stronger market position by tackling significant threats to poultry farming.

Company Intelligence Q&A

What is eggXYt's core technology?

eggXYt develops a CRISPR-based proprietary technology that identifies the sex of chick embryos immediately after eggs are laid, prior to the 21-day incubation period. This prevents the unnecessary hatching of male chicks.

When was eggXYt founded and by whom?

eggXYt was founded in October 2016 by Yehuda Elram, Daniel Offen, and Gal Lin.

What strategic partnership did eggXYt form to combat avian influenza?

In December 2020, eggXYt licensed the GEiGS™ Technology Platform from Tropic Biosciences to develop resistance against the Avian Influenza Virus in chickens.

What award did eggXYt receive in 2019?

In March 2019, eggXYt won the Technology Research Award at CleanEquity® Monaco 2019, hosted by Innovator Capital.